Trial intelligence / Profile preview

Capecitabine as first-line monotherapy in HER2-negative metastatic breast cancer (Phase II)

2005-000074-51Phase 2Completed

Sponsor

GBG Forschungs

Start

Feb 2005

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1